MRI and PET studies of manganese-intoxicated monkeys

H Shinotoh1, B J Snow, K A Hewitt

  • 1Neurodegenerative Disorders Centre, University of British Columbia, Vancouver, Canada.

Neurology
|June 1, 1995
PubMed

Insights

Manganese intoxication in primates caused parkinsonism by damaging downstream pathways, not the nigrostriatal dopaminergic pathway. This explains the lack of response to levodopa treatment.

Area of Science:

  • Neuroscience
  • Toxicology
  • Primate Models

Background:

  • Manganese is an essential element, but chronic intoxication can lead to neurological disorders resembling Parkinson's disease.
  • The exact mechanisms by which manganese induces parkinsonian symptoms remain unclear.

Purpose of the Study:

  • To investigate the neurological consequences of manganese intoxication in a primate model.
  • To determine the impact of manganese on the nigrostriatal dopaminergic pathway and related motor functions.

Main Methods:

  • Three rhesus monkeys received intravenous manganese chloride (MnCl2) injections over seven weeks.
  • Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET) scans were used to assess brain changes.
  • Clinical motor assessments and levodopa response were evaluated.

Main Results:

  • Manganese-intoxicated monkeys exhibited hypoactivity and abnormal posturing, unresponsive to levodopa.
  • T1-weighted MRI revealed high signal intensities in the striatum, globus pallidus, and substantia nigra.
  • PET scans showed no significant changes in dopaminergic pathways or glucose metabolism.

Conclusions:

  • Manganese intoxication in primates causes parkinsonian deficits through damage to pathways downstream of the nigrostriatal dopaminergic system.
  • The dopaminergic pathway remains intact, explaining the lack of therapeutic response to levodopa.
  • Chronic manganese exposure may induce parkinsonism via extrastriatal mechanisms.